ATYR Q2 2024 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$17M

Net Income

-$16M

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$727,000

Balance Sheet

Total Assets

$106M

Total Liabilities

$25M

Stockholders' Equity

$82M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$586,000	+100.0%
Operating Income	-$17M	-$14M	-27.7%
Net Income	-$16M	-$12M	-32.2%